Does testosterone intake affect diagnosing primary HIV infection?
DOI:
https://doi.org/10.56782/pps.124Keywords:
Exogenous steroids, HIV diagnostics, Klinefelter syndrome, Primary HIV infection, TestosteroneAbstract
Diagnosis of primary HIV infection may be disrupted by many factors, one of which are drugs such as exogenous steroids. We report a rare case of a 37-year-old male patient, undergoing testosterone treatment in the course of Klinefelter syndrome. He presented with the general symptoms of fever, weakness and diarrhea lasting for 2 weeks. He also had incorrect results of laboratory studies. The fourth generation ELISA HIV test indicated negative outcomes. The HIV real time polymerase chain reaction test was performed and showed very high plasma viral load, over 107 copies/ml. We discuss the connection between androgen replacement therapy used in Klinefelter syndrome and the diagnosis of PHI. This case report illustrates the importance of obtaining a detailed medical history, especially of chronic diseases and medications, and applying appropriate diagnostic tests.
Downloads
References
European AIDS Clinical Society Guidelines, Version 10.1, October 2020.
Pincus JM, Crosby SS, Losina E, et al. Acute Human Immunodeficiency Virus infection in patients presenting to an urban urgent care center. Clin Infect Dis. 2003; https://doi.org/10.1086/379772. DOI: https://doi.org/10.1086/379772
Tsybina P, Hennink M, Diener T, et al. Repeated false reactive ADVIA centaur® and bio-rad Geenius™ HIV tests in a patient self-administering anabolic steroids. BMC Infect Dis. 2020; https://doi.org/10.1186/s12879-019-4722-8. DOI: https://doi.org/10.1186/s12879-019-4722-8
Lee K, Park H, Kang E. Reduction of the HIV seroconversion window period and false positive rate by using ADVIA centaur HIV antigen/antibody combo assay. Ann Lab Med. 2013; https://doi.org/10.3343/alm.2013.33.6.420.6. DOI: https://doi.org/10.3343/alm.2013.33.6.420
Serhir B, Desjardins C, Doualla-Bell F, et al. Evaluation of the bio-rad Geenius HIV 1/2 assay as part of a confirmatory HIV testing strategy for Quebec, Canada: comparison with Western blot and Inno-Lia assays. J Clin Microbiol. 2019; https://doi.org/10.1128/JCM.01398-18. DOI: https://doi.org/10.1128/JCM.01398-18
Padeh YC, Rubinstein A, Shliozberg J. Common variable immunodeficiency and testing for HIV-1. N Engl J Med. 2005; 10:1074-1075. DOI: https://doi.org/10.1056/NEJMc051339
Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors; implications for diagnosis and staging of primary HIV infection. AIDS. 2003; 17:1871-1879. DOI: https://doi.org/10.1097/00002030-200309050-00005
Cohen MS, Gay CL, Busch MP, et al. The Detection of Acute HIV Infection. J Infect Dis. 2010; https://doi.org/10.1086/655651. DOI: https://doi.org/10.1086/655651
Robb Merlin L, Ananworanich J. Lessons from acute HIV infection. Curr Opin HIV AIDS. 2016; https://doi.org/10.1097/COH.0000000000000316. DOI: https://doi.org/10.1097/COH.0000000000000316
McMichael A, Borrow P, Tomaras G, et al. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010; https://doi.org/10.1038/nri2674. DOI: https://doi.org/10.1038/nri2674
Chinen J, Shearer WT. Molecular virology and immunology of HIV infection. J Allergy Clin Immunol. 2002; https://doi.org/10.1067/mai.2002.126226. DOI: https://doi.org/10.1067/mai.2002.126226
Liu P, Jackson P, Shaw N, et al. Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests. AIDS Res Ther. 2016; https://doi.org/10.1186/s12981-015-0086-3. DOI: https://doi.org/10.1186/s12981-015-0086-3
Stekler JD, Violette LR, Niemann L, et al. Repeated false-positive HIV test results in a patient taking HIV preexposure prophylaxis. Open Forum Infect Dis. 2018; https://doi.org/10.1093/ofid/ofy197. DOI: https://doi.org/10.1093/ofid/ofy197
Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005; 11:411–423. DOI: https://doi.org/10.1093/humupd/dmi008
Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol. 2015; https://doi.org/10.1016/j.cellimm.2015.02.004. DOI: https://doi.org/10.1016/j.cellimm.2015.02.004
Ananworanich J, Sacdalan CP, Pinyakorn S, et al. Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection. J Virus Erad. 2016; 2(1):43-48. DOI: https://doi.org/10.1016/S2055-6640(20)30688-9
Koçar IH, Yesilova Z, Ozata M, et al. The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome. Clin Exp Immunol. 2000; https://doi.org/10.1046/j.1365-2249.2000.01329.x. DOI: https://doi.org/10.1046/j.1365-2249.2000.01329.x
Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, Viral Load, and Viral Load Set Point in primary HIV infection. J Acquir Immune Defic Syndr. 2007; https://doi.org/10.1097/QAI.0b013e318074ef6e. DOI: https://doi.org/10.1097/QAI.0b013e318074ef6e
Sanders EJ, Wahome E, Powers KA, et al. Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS. 2015; https://doi.org/10.1097/QAD.0000000000000924. DOI: https://doi.org/10.1097/QAD.0000000000000924
Prins HAB, Verbon A, Boucher CAB, et al. Ending the epidemic: Critical role of primary HIV infection. Neth J Med. 2017; 75(8):321-327.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Olga Grelewicz, Gabriela Kulbacka, Tomasz Mikuła, Alicja Wiercińska-Drapało
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
